SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-021181
Filing Date
2006-03-31
Accepted
2006-03-31 14:27:46
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-8034_110k.htm 10-K 1840849
2 MATERIAL CONTRACTS a06-8034_1ex10d32.htm EX-10.32 3797
3 MATERIAL CONTRACTS a06-8034_1ex10d33.htm EX-10.33 24965
4 CONSENTS OF EXPERTS AND COUNSEL a06-8034_1ex23d1.htm EX-23.1 2688
5 302 CERTIFICATION a06-8034_1ex31d1.htm EX-31.1 11283
6 302 CERTIFICATION a06-8034_1ex31d2.htm EX-31.2 11280
7 906 CERTIFICATION a06-8034_1ex32d1.htm EX-32.1 5859
8 906 CERTIFICATION a06-8034_1ex32d2.htm EX-32.2 5861
  Complete submission text file 0001104659-06-021181.txt   1908111
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31812 | Film No.: 06727818
SIC: 2836 Biological Products, (No Diagnostic Substances)